PLLWF (Polarean Imaging) PS Ratio: 3.30 (As of Jul. 03, 2026) — 69% Below Median


What is Polarean Imaging PS Ratio?

Polarean Imaging PLLWF +560.00% PS Ratio is 3.30 as of Jul. 03, 2026, which is 69% below its 10-year median of 10.52. The stock has 4 warning signs investors should review.

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Polarean Imaging's share price is $0.0066. Polarean Imaging's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2025 was $0.00. Hence, Polarean Imaging's PS Ratio for today is 3.30.

The historical rank and industry rank for Polarean Imaging's PS Ratio or its related term are showing as below:

PLLWF' s PS Ratio Range Over the Past 10 Years
Min: 0.25   Med: 10.52   Max: 160.5
Current: 3.3

During the past 9 years, Polarean Imaging's highest PS Ratio was 160.50. The lowest was 0.25. And the median was 10.52.

PLLWF's PS Ratio is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.94 vs PLLWF: 3.30

Polarean Imaging's Revenue per Sharefor the six months ended in Jun. 2025 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2025 was $0.00.

Warning Sign:

Polarean Imaging PLC revenue per share has been in decline for the last 5 years.

During the past 12 months, the average Revenue per Share Growth Rate of Polarean Imaging was -71.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was -7.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was -22.60% per year.

During the past 9 years, Polarean Imaging's highest 3-Year average Revenue per Share Growth Rate was -7.20% per year. The lowest was -70.60% per year. And the median was -42.20% per year.

Back to Basics: PS Ratio


Polarean Imaging  (OTCPK:PLLWF) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Polarean Imaging PS Ratio Related Terms


Polarean Imaging PS Ratio Historical Data

* Premium members only.

The historical data trend for Polarean Imaging's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Polarean Imaging PS Ratio Chart

Polarean Imaging Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PS Ratio
Get a 7-Day Free Trial Premium Member Only 41.73 98.36 120.38 14.45 3.75

Polarean Imaging Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 14.45 0.00 3.75 0.00

PLLWF vs FOFA, BTCY, LFWD: PS Ratio Comparison

For the Medical Devices subindustry, Polarean Imaging's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polarean Imaging PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Polarean Imaging's PS Ratio distribution charts can be found below:

* The bar in red indicates where Polarean Imaging's PS Ratio falls into.



Polarean Imaging PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Polarean Imaging's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=0.0066/0.002
=3.30

Polarean Imaging's Share Price of today is $0.0066.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Polarean Imaging's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2025 was $0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.

Frequently Asked Questions Learn more about PS Ratio →
What does a PS Ratio of 3.30 mean?
Polarean Imaging (PLLWF) has a PS Ratio of 3.30 as of Jul. 03, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Polarean Imaging and its competitors. This is 69% below median its historical median of 10.52. Over the past decade, Polarean Imaging's PS Ratio has ranged from 0.25 to 160.50.
Is Polarean Imaging's PS Ratio too high?
Polarean Imaging's current PS Ratio of 3.30 is 69% below median its 10-year median of 10.52. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 160.50. The Medical Devices & Instruments industry median PS Ratio is 2.94. Polarean Imaging's value of 3.30 is 12.2% above this industry median.
How does Polarean Imaging's PS Ratio compare to FOFA and BTCY?
Polarean Imaging's PS Ratio of 3.30 can be compared against companies in the Medical Devices & Instruments industry. The industry median PS Ratio is 2.94. Polarean Imaging's value of 3.30 is 12.2% above this benchmark. Historically, Polarean Imaging's own PS Ratio has ranged from 0.25 to 160.50 over the past decade. While the company's 10-year median is 10.52 vs. the industry median of 2.94, Polarean Imaging has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Polarean Imaging's current PS Ratio of 3.30 is 12.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Polarean Imaging and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Polarean Imaging's current PS Ratio is 3.30, which is 69% below median its own 10-year median of 10.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Polarean Imaging stock overvalued right now?
Polarean Imaging (PLLWF) has a current PS Ratio of 3.30. The stock's GF Value™ is $0.04, compared to a current price of $0.01 — trading 83.5% below its estimated fair value. The current PS Ratio is 3.30, which is 69% below median its 10-year median of 10.52 and 12.2% above the Medical Devices & Instruments industry median of 2.94. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Polarean Imaging (PLLWF), the current PS Ratio is 3.30 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Polarean Imaging Business Description

Address 27-28 Eastcastle Street, London, GBR, W1W 8DH
Polarean Imaging PLC designs and manufactures medical drug-device combination companies operating in the high-resolution medical imaging market. Its only operating segment is the development and commercialization of gas polariser devices and ancillary instruments. Geographically, it derives the majority of its revenue from the United States of America and also has a presence in Canada and the United Kingdom. The company generates revenue from products and services such as Polarisers, Parts and Upgrades, Service, and other revenue. Its product portfolio includes 9820 129Xe Hyperpolarizer, 9800 129Xe Hyperpolarizer, Polarean 3777 129Xe Hyperpolarizer Upgrade Module, Polarean 2881 Polarization Measurement Station, and others.